Literature DB >> 24990106

Presence of sarcopenia (muscle wasting) in patients with nonalcoholic steatohepatitis.

Danny Issa1, Naim Alkhouri, Cynthia Tsien, Shetal Shah, Rocio Lopez, Arthur McCullough, Srinivasan Dasarathy.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24990106      PMCID： PMC4539562          DOI： 10.1002/hep.26908

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning.

Authors:  Morgan E Levine; Eileen M Crimmins
Journal:  Obesity (Silver Spring)       Date:  2012-02-07       Impact factor: 5.002

Review 2.  New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients.

Authors:  A J Montano-Loza
Journal:  Minerva Gastroenterol Dietol       Date:  2013-06

3.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

4.  A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.

Authors:  Marina Mourtzakis; Carla M M Prado; Jessica R Lieffers; Tony Reiman; Linda J McCargar; Vickie E Baracos
Journal:  Appl Physiol Nutr Metab       Date:  2008-10       Impact factor: 2.665

5.  Nonalcoholic fatty liver disease in patients with type 2 diabetes.

Authors:  Zobair M Younossi; Terry Gramlich; Christi A Matteoni; Navdeep Boparai; Arthur J McCullough
Journal:  Clin Gastroenterol Hepatol       Date:  2004-03       Impact factor: 11.382
  5 in total
  11 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 2.  Sarcopenia and fatty liver disease.

Authors:  Jung A Kim; Kyung Mook Choi
Journal:  Hepatol Int       Date:  2019-11-08       Impact factor: 6.047

3.  Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.

Authors:  Daniel Cabrera; Alex Ruiz; Claudio Cabello-Verrugio; Enrique Brandan; Lisbell Estrada; Margarita Pizarro; Nancy Solis; Javiera Torres; Francisco Barrera; Marco Arrese
Journal:  Dig Dis Sci       Date:  2016-08-29       Impact factor: 3.199

4.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

5.  Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.

Authors:  Louise Johanna Maria Alferink; Katerina Trajanoska; Nicole Stephanie Erler; Josje Dorothea Schoufour; Robert Jacobus de Knegt; M Arfan Ikram; Harry Leonardus Antonius Janssen; Oscar H Franco; Herold J Metselaar; Fernando Rivadeneira; Sarwa Darwish Murad
Journal:  J Bone Miner Res       Date:  2019-05-10       Impact factor: 6.741

6.  Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease.

Authors:  Hwi Young Kim; Su Jung Baik; Hye Ah Lee; Byoung Kwon Lee; Hye Sun Lee; Tae Hun Kim; Kwon Yoo
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

Review 7.  Current treatment of non-alcoholic fatty liver disease.

Authors:  Rafael Paternostro; Michael Trauner
Journal:  J Intern Med       Date:  2022-07-07       Impact factor: 13.068

Review 8.  Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?

Authors:  Ivana Mikolasevic; Tajana Pavic; Tajana Filipec Kanizaj; Darija Vranesic Bender; Viktor Domislovic; Zeljko Krznaric
Journal:  Can J Gastroenterol Hepatol       Date:  2020-10-31

9.  Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models.

Authors:  Maxime Nachit; Maxime De Rudder; Jean-Paul Thissen; Olivier Schakman; Caroline Bouzin; Yves Horsmans; Greetje Vande Velde; Isabelle Anne Leclercq
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-11-26       Impact factor: 12.910

Review 10.  Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease.

Authors:  Vittoria Zambon Azevedo; Cristina Alina Silaghi; Thomas Maurel; Horatiu Silaghi; Vlad Ratziu; Raluca Pais
Journal:  Front Nutr       Date:  2022-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.